Cambridge Investment Research Advisors’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17K | Buy |
|
|||||
|
2025
Q1 | $17K | Hold |
|
|||||
|
2024
Q4 | $26K | Hold |
|
|||||
|
2024
Q3 | $22K | Buy |
|
|||||
|
2024
Q2 | $9K | Buy |
|
|||||
|
2024
Q1 | $17K | Sell |
|
|||||
|
2023
Q4 | $17K | Sell |
|
|||||
|
2023
Q3 | $19K | Hold |
|
|||||
|
2023
Q2 | $40K | Hold |
|
|||||
|
2023
Q1 | $54K | Hold |
|
|||||
|
2022
Q4 | $97K | Sell |
|
|||||
|
2022
Q3 | $151K | Hold |
|
|||||
|
2022
Q2 | $128K | Buy |
|
|||||
|
2022
Q1 | $168K | Sell |
|
|||||
|
2021
Q4 | $217K | Sell |
|
|||||
|
2021
Q3 | $266K | Sell |
|
|||||
|
2021
Q2 | $354K | Sell |
|
|||||
|
2021
Q1 | $436K | Hold |
|
|||||
|
2020
Q4 | $543K | Buy |
|
|||||
|
2020
Q3 | $283K | Sell |
|
|||||
|
2020
Q2 | $269K | Hold |
|
|||||
|
2020
Q1 | $191K | Hold |
|
|||||
|
2019
Q4 | $251K | Buy |
|
|||||
|
2019
Q3 | $207K | Buy |
|
|||||
|
2019
Q2 | $210K | Buy |
|
|||||
|
2019
Q1 | $184K | Buy |
|
|||||
|
2018
Q4 | $187K | Buy |
|
|||||
|
2018
Q3 | $182K | Buy |
|